H&T Presspart, a Division of the Heitkamp & Thumann Group, has acquired Plas-Tech Engineering for an undisclosed amount. This corporate acquisition sees H&T Presspart taking ownership of the medical device manufacturing company, expanding its capabilities within the healthcare sector. The transaction represents a strategic move to integrate specialized expertise and production capacity.
Plas-Tech Engineering, located in Lake Geneva, Wisconsin, is a medical device manufacturing company with over three decades of experience. It is ISO 13485 and FDA registered, specializing in product design, development, and manufacturing for medical devices, components, and disposables. The company operates ISO Class VI Clean Room and ISO Class VIII Manufacturing facilities, emphasizing early design involvement to optimize manufacturability and cost. Plas-Tech is particularly known for its extensive experience in developing and manufacturing custom syringes for prefilled pharmaceutical applications using COC and COP polymers, as well as highly technical insert molding for medical applications.
The acquisition is strategically significant for H&T Presspart, enabling it to strengthen its position in advanced medical manufacturing. Plas-Tech Engineering’s specialized capabilities in custom syringe production, complete medical device manufacturing, and cleanroom operations are expected to complement H&T Presspart’s existing portfolio. This integration provides synergistic opportunities, allowing the combined entity to offer more comprehensive solutions and enhance its presence in critical pharmaceutical and medical device markets, particularly in advancing parenteral applications.
This acquisition is set to create a combined entity with expanded manufacturing prowess and a broader service offering. The integration of Plas-Tech Engineering's design, development, and manufacturing expertise with H&T Presspart is anticipated to drive innovation and provide enhanced value to customers in the global medical and pharmaceutical industries.